DUBLIN--(BUSINESS WIRE)--The "UK Clinical Negligence Market 2021- Market Data Report" report has been added to ResearchAndMarkets.com's offering.
Across the UK, the publisher estimates that £3.5 billion was paid out in CN cases in 2020/21, most of this by public sector health bodies, via the main public indemnity organisations or directly by departments for health and public health organisations.
In 2020/21, they estimate law firms earned revenue of over £1.0 billion from CN cases. This represents little change on the level of legal fees for 2019/20, because of the impact of COVID-19 on cases handled.
There remains a large pipeline of future cases to be handled, with state backed indemnity organisations, medical defence organisation, private sector healthcare providers and insurers, probably holding around £150 billion in provisions and contingent liabilities to cover potential future CN payments.
Key Topics Covered:
EXECUTIVE SUMMARY
- Around £3.5 billion spent annually on CN cases
- Law firms earn over £1bn annually from CN cases
- With case numbers down in 2020 because of COVID
- But a substantial case load going forward
- Four key participants for a market in two halves
- Key recent developments and market drivers
INTRODUCTION
- Two types of damage payments
- Lump sum payment and the PIDR
- Abbreviations
MARKET STRUCTURE
- Four main market participants
- It's a market in two halves
- Clinical negligence indemnity/insurance cover
- Individual indemnity and insurance cover is still required
- The Clinical Negligence protocol
MARKET DRIVERS
- Coronavirus
- The Coronavirus Act 2020 - Clinical Negligence Scheme for Coronavirus (CNSC)
- Medical Defence Organisations also widen their cover
- COVID-19 may increase future risks
- COVID-19 leads to changes in how CN cases are handled and investigated
- New NHS Resolution Business Plan
- Average awards continue to increase
- Obstetrics, the main cause of claims inflation
- Number of CN cases going through the courts declines
- Health grounds defence may be removed
THE KEY PLAYERS
- Overview
- Indemnity Organisations
- Other medical malpractice insurance and indemnity providers
- Claimant and defendant legal advice - two separate market segments
- Selected Law Firm Profiles
- A small selection of law firms involved in CN cases are profiled below.
MARKET SIZE AND TRENDS
- COVID-19 cuts new case numbers in 2020
- Public Indemnity Organisations account for the bulk of cases
- Around 30% of CN payment present legal fees
- Clinical negligence legal revenue
THE FUTURE
- Potential reform of the process of handling lower value CN claims
- Potential introduction of fixed Recoverable costs
- Changes to the Guideline Hourly Rate
- The Commons Health and Social Care Committee calls for changes in the CN process
- Potential expenditures in the pipeline
ASSOCIATIONS
For more information about this report visit https://www.researchandmarkets.com/r/cxwarp
